Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2016-12-28 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于召开2017年第一次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a notice for the convening of the 2017 first extraordinary general meeting of shareholders of Changchun Dirui Medical Technology Co., Ltd. It includes details about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration methods, and proxy forms. There is no financial data or report content, but rather an announcement and instructions related to a shareholders' meeting. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is over 5,000 characters and contains detailed meeting information, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is AGM Information (AGM-R).
2016-12-28 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically the nomination of a board member. The document length is 3242 characters, which is relatively short and does not contain financial data or report publication language. Therefore, it fits best under the category of Board/Management Information (MANG).
2016-12-28 Chinese
独立董事候选人声明（徐杉）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Changchun Dirui Medical Technology Co., Ltd. It contains detailed statements confirming the candidate's qualifications and compliance with relevant laws and regulations for serving as an independent director. There are no financial statements, earnings data, or report summaries. The document is a candidate's declaration related to board/management matters, specifically about the appointment of an independent director. This fits the category of Board/Management Information (MANG). The document length is 3235 characters, which is relatively short and focused on a specific management-related declaration rather than a full report or announcement of a report.
2016-12-28 Chinese
第三届董事会第二次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting, including nominations for independent directors, changes to the company's business scope and articles of association, and the scheduling of a shareholders' meeting. It includes voting results and references to further announcements on a regulatory information website. The content focuses on board decisions and governance matters rather than financial results or reports. The document length is short (1437 characters) and it is clearly a meeting resolution announcement, not a full report or financial statement. Therefore, the appropriate classification is Board/Management Information (MANG).
2016-12-28 Chinese
关于部分募投项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Changchun Dirui Medical Technology Co., Ltd. regarding the delay of certain projects funded by raised capital. It references regulatory compliance with Shenzhen Stock Exchange rules and the China Securities Regulatory Commission approval for the initial public offering. The document details the use of raised funds, project investment amounts, progress, and reasons for delay. It includes opinions from the board of directors, supervisory board, independent directors, and the sponsoring institution. The document is relatively short (3369 characters) and primarily serves as a formal announcement about the delay of capital investment projects rather than a full financial report or detailed financial statements. It does not contain comprehensive financial data or analysis but focuses on the management and regulatory disclosure of capital project delays. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including the management of raised funds and project progress.
2016-12-27 Chinese
关于公司独立董事辞职的公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of an independent director from the company's board. It details the resignation, the impact on board composition, and the company's plan to nominate a new director. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the director change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2016-12-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.